Skip to content

Day: April 23, 2018


Iowa-based IDx receives FDA permit to market first ever autonomous AI diagnostic system

By Christine McGuigan / April 23, 2018

Privately-held AI diagnostics company IDx announced earlier this month that the U.S. Food and Drug Administration (FDA) has granted the company’s De Novo request to market IDx-DR. IDx-DR is an AI-based diagnostic system for the autonomous detection of diabetic retinopathy, a leading cause of blindness. More than 30 million Americans have diabetes, and an estimated…

Read More